Biblio

Found 28 results
Author Keyword Title Type [ Year(Asc)]
Filters: Keyword is Risk Factors  [Clear All Filters]
2017
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, Carrell D, Cai Y, Fernández MVictoria, Budde J et al..  2017.  Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.. Acta Neuropathol. 133(5):839-856.
2016
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA, Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.  2016.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.. Alzheimers Dement. 12(2):121-129.
2015
Greven CU, Bralten J, Mennes M, O'Dwyer L, van Hulzen KJE, Rommelse N, Schweren LJS, Hoekstra PJ, Hartman CA, Heslenfeld D et al..  2015.  Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.. JAMA Psychiatry. 72(5):490-9.
Mukherjee S, Walter S, Kauwe JSK, Saykin AJ, Bennett DA, Larson EB, Crane PK, M Glymour M.  2015.  Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.. Alzheimers Dement. 11(12):1439-1451.
Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen C-H et al..  2015.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.. Circulation. 131(23):2061-2069.
2014
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W et al..  2014.  An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.. PLoS Genet. 10(3):e1004211.
2013
Thambisetty M, An Y, Tanaka T.  2013.  Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.
Cruchaga C, Kauwe JSK, Harari O, Jin SChih, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D et al..  2013.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.. Neuron. 78(2):256-68.
Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD et al..  2013.  Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).. Transl Psychiatry. 3:e256.
2012
De Jager PL, Shulman JM, Chibnik LB, Keenan BT, Raj T, Wilson RS, Yu L, Leurgans SE, Tran D, Aubin C et al..  2012.  A genome-wide scan for common variants affecting the rate of age-related cognitive decline.. Neurobiol Aging. 33(5):1017.e1-15.
Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.  2012.  Overview and findings from the religious orders study.. Curr Alzheimer Res. 9(6):628-45.
2011
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al..  2011.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
2007
Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ et al..  2007.  GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.. Neuron. 54(5):713-20.
2006
Xu P-T, Li Y-J, Qin X-J, Scherzer CR, Xu H, Schmechel DE, Hulette CM, Ervin J, Gullans SR, Haines J et al..  2006.  Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.. Neurobiol Dis. 21(2):256-75.
Akomolafe A, Lunetta KL, Erlich PM, Cupples LA, Baldwin CT, Huyck M, Green RC, Farrer LA.  2006.  Genetic association between endothelial nitric oxide synthase and Alzheimer disease.. Clin Genet. 70(1):49-56.
Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL et al..  2006.  Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
Smemo S, Nowotny P, Hinrichs AL, Kauwe JSK, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM et al..  2006.  Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.. Ann Neurol. 59(1):21-6.
2005
Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P et al..  2005.  Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.. Am J Med Genet B Neuropsychiatr Genet. 136B(1):62-8.
Zhu H, Gopalraj RK, Kelly JF, Bennett DA, Estus S.  2005.  Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.. Neurosci Lett. 381(1-2):36-41.
Slifer MA, Martin ER, Haines JL, Pericak-Vance MA.  2005.  The ubiquilin 1 gene and Alzheimer's disease.. N Engl J Med. 352(26):2752-3;authorreply2752-3.
2004
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al..  2004.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA et al..  2004.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.